Cargando…
Qingluoyin granules protect against adjuvant-induced arthritis in rats via downregulating the CXCL12/CXCR4-NF-κB signalling pathway
CONTEXT: Qingluoyin (QLY) is a traditional Chinese medicine (TCM) formula which has been used in treating human rheumatoid arthritis (RA) for years in China. OBJECTIVE: This study investigates the effect of QLY granules on adjuvant arthritis (AA) and the possible mechanism. MATERIALS AND METHODS: Sp...
Autores principales: | Si, Min, Ma, Zheng, Zhang, Jie, Li, Xinwei, Li, Rui, Wang, Chao, Jia, Huiyu, Luo, Shengyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547818/ https://www.ncbi.nlm.nih.gov/pubmed/34693865 http://dx.doi.org/10.1080/13880209.2021.1991386 |
Ejemplares similares
-
Xiaoyao-Qingluoyin Cure Adjuvant-Induced Arthritis by Easing LPS Response-Related Pathway-Mediated Immune Abnormality
por: Li, Dan-Feng, et al.
Publicado: (2022) -
CXCR7 Functions as a Scavenger for CXCL12 and CXCL11
por: Naumann, Ulrike, et al.
Publicado: (2010) -
CXCL12/SDF-1 and CXCR4
por: Nagasawa, Takashi
Publicado: (2015) -
Expression levels of CXCR4 and CXCL12 in patients with rheumatoid arthritis and its correlation with disease activity
por: Peng, Liping, et al.
Publicado: (2020) -
Expression and function of CXCL12/CXCR4/CXCR7 in thyroid cancer
por: ZHU, XIAOLI, et al.
Publicado: (2016)